The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Scotts Miracle-Gro's revenues will drop -3.4% and EPS will compress -6.5%.
The average estimate for revenue is $1.13 billion. On the bottom line, the average EPS estimate is $2.01.
Last quarter, Scotts Miracle-Gro booked revenue of $205.8 million. GAAP reported sales were 3.1% higher than the prior-year quarter's $199.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$1.12. GAAP EPS were -$1.10 for Q1 compared to -$1.21 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 15.1%, 230 basis points better than the prior-year quarter. Operating margin was -42.6%, 570 basis points better than the prior-year quarter. Net margin was -32.9%, 410 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.89 billion. The average EPS estimate is $2.63.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 218 members out of 245 rating the stock outperform, and 27 members rating it underperform. Among 88 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 82 give Scotts Miracle-Gro a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Scotts Miracle-Gro is hold, with an average price target of $43.80.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Scotts Miracle-Gro to My Watchlist.